PMB Review: What s next? Evelyn Thsehla Clinical Researcher

Similar documents
2008 PMB Review consultation document. Proposed construct and work plans. 27 March 2008

Methodology to assess the cost impact of PMB benefit definitions

Contribution inflation in Medical Schemes

REPORT ON ANALYSIS OF MEDICAL SCHEMES CLAIMS DATA- A FOCUS ON PRESCRIBED MINIMUM BENEFITS 8 DECEMBER 2017

Guideline for the preparation of a business plan pursuant to an application for an amalgamation of medical schemes as per Section 63 of the Medical

I (E)nsuring Access to Healthcare

Guideline for the preparation of a business plan pursuant to an application for the registration of a new/restructured benefit option(s) as per

Guideline for the preparation of a business plan pursuant to an application for the registration of a new/restructured benefit option(s) as per

Circular 33 of 2018: Guidance on benefit changes and contribution increases for 2019

Prescribed Minimum Benefit compliance and the protection of beneficiaries. Council for Medical Schemes PMB Compliance workshop 11 May 2010

CIRCULAR 4 OF 2013: EVALUATION OF COST INCREASE ASSUMPTIONS BY MEDICAL SCHEMES FOR 2013 FINANCIAL YEAR

Discovery Health Note to Investors on recent regulatory developments

LOW COST BENEFIT OPTION FRAMEWORK. Paresh Prema GM: Benefits Management CMS Indaba 8 September 2015

REPORT ON ANALYSIS OF MEDICAL SCHEMES CLAIMS DATA- INITIAL COST ATTRIBUTION ANALYSIS VERSION 2: 8 DECEMBER 2017

A regulators perspective: evidence of anti-selection and experience in addressing risk pooling failures and benefit design

EFFICIENCY DISCOUNTED OPTIONS VALUE PROPOSITION. Mondi Govuzela 06 July 2017

MEDICAL SCHEMES ACT OF SOUTH AFRICA AMENDMENT BILL, 2018

Healthcare regulatory reform where to?

HEALTHCARE EXPENDITURE IN THE LAST YEAR OF LIFE

DICO Regulatory Guidance

HEALTH MARKET INQUIRY

CMS view on meaningful risk pooling in pursuit of Universal Health Coverage

Defining the Benefit Package

Health Sector Strategy. Khyber Pakhtunkhwa

Evaluation of cost increase assumptions by medical schemes for the 2012 financial year

Translating Health Data into Community Change

CIRCULAR 23 OF 2015: EVALUATION OF COST INCREASE ASSUMPTIONS BY MEDICAL SCHEMES FOR 2015 FINANCIAL YEAR

Opportunities and Challenges for Public sector Medical Insurance Schemes in a Private Sector Ms B Mfenyana 06 October 2016 Second colloquium

Presentation to SAMA Conference 2015

Risk adjustment is an important opportunity to ensure the sustainability of the exchanges and coverage for patients with chronic conditions.

Metropolitan Greenfield Growth Area ICPs Benchmark Costings Consultation Session

Overview. A summary of the principles included in this document are:

Hospital Alternative Reimbursement Models, and DRGs

Challenges and opportunities for health finance in South Africa: a supply and regulatory perspective

Implementing the DSRIP Finance Function

Resource Allocation Charter Document

Comment and input in preparation for the seminar on the regulation of healthcare financing

DENTAL PROGRAM UPDATE

Report of The Health Insurance Authority to the Minister for Health and Children pursuant to Article 10 of the Risk Equalisation Scheme, 2003 and for

TABLE OF CONTENTS SUBJECTS 1. INTRODUCTION 2. INSTITUTIONAL ARRANGEMENTS. Roles and responsibilities

Centers for Medicare & Medicaid Services: Innovation Center New Direction Request For Information: Medicare Advantage (MA) Innovation Models

Affordable Care Act Implementation Alert

WYOMING MEDICAID IMPLEMENTATION OF APR DRGS

ACCREDITATION STANDARDS FOR MANAGED CARE ORGANISATIONS

Government Bond Market Development in Myanmar

Presentation to the Portfolio Committee on Health Dr Jonathan Broomberg Dr Penny Tlhabi Discovery Health 2 June 2010

Annexures to the report on the analysis of REF shadow returns

Initiative of National Department of Health to accelerate Health Infrastructure Service Delivery

NH Community Behavioral Health Association Workforce Challenges and Opportunities

Measuring performance for objective based funds. Chris Durack, Head of Distribution and Product, Schroder Investment Management Australia Limited

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

Public Hearing Presentation Retaining Value and Quality in a changing healthcare landscape

May 23, The Honorable Orrin Hatch Chairman Senate Finance Committee 219 Dirksen Building Washington, D.C Dear Chairman Hatch:

ALLIANCE DOUBLE PLUS VITAL ESSENTIAL FIRST CHOICE NETWORK CHOICE

ZIMBABWE HEALTH FINANCING. GWATI GWATI Health Economist: Planning and Donor Coordination MOHCC Technical team leader National Health Accounts.

Association of Chartered Professional Accountants of Newfoundland and Labrador

Guideline for the preparation of Standard Management Accounts

UK s withdrawal from the EU - preparedness activities update

Implementing digital claim hospital verification in National Health Social Security in Indonesia

REPORT ON ANALYSIS OF MEDICAL SCHEMES CLAIMS DATA: A FOCUS ON FUNDERS VERSION: 15 DECEMBER 2017

FEDERAL TRADE COMMISSION/DEPARTMENT OF JUSTICE PROPOSED STATEMENT OF ANTITRUST ENFORCEMENT POLICY REGARDING ACCOUNTABLE CARE ORGANIZATIONS

Aadhaar Enabled Administration of Health Insurance in Sikkim, India. Pompy Sridhar 12 th International Microinsurance Conference 2016

CIGNA FUNDING OPTIONS

Presented by: Steven Flores. Prepared for: The Predictive Modeling Summit

Rulemaking implementing the Exchange provisions, summarized in a separate HPA document.

Housing Operations. Housing Division Re-Organization. Rent Supplement Deficit 2016 Audit Results 2018 Operating Budget(s) Next Steps

City of Menifee Development Code Update

SOUTH AFRICAN DENTAL ASSOCIATION - COMMENTS ON DRAFT TERMS OF. 1.1 We refer to the document issued by the Competition Commission

Part One: FEDERAL POLICY AND MEDICARE S IMPACT ON THE ECONOMY

Factsheet on the Non-Negotiable Budget Items in the Provision of Public Health and HIV/AIDS Services in South Africa 1

Session 1: Mandated Report: Medicare Payment for Ambulance Services

THE CONSTITUTIONALITY OF THE NHI SCHEME AS A FINANCING SYSTEM FOR UNIVERSAL HEALTH COVERAGE

August 2018: Monthly Data Update

Utilisation of medical services

The Costing of the Proposed Chronic Disease List Benefits in South African Medical Schemes in 2001

GLOBAL CREDIT RATING CO: SA MEDICAL SCHEMES RATINGS BULLETIN

Guidelines for the preparation of a business plan pursuant to an application for the registration of a new Friendly Society as per Section 5 (1) of

REGIONAL PLANNING CONSORTIUMS LONG ISLAND PARTNERSHIP 2nd STAKEHOLDER MEETING DECEMBER 16, 2016

Get Straight on MACRA in 2018

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014

Summary of 2017 Medicare Part D Final Call Letter

Title I - Health Care Coverage

CONTROLLED DOCUMENT. Version Number: 4.1. On: January 2018 Review Date: June 2016 Distribution: Essential Reading for: Information for: 1 of 15

THE SELF-EVALUATION CHECKLIST

Health Insurance and Children s Well-Being

In accordance with Act 124 of 2018 (H.914)

National Treasury. Financing NHI. Pharmaceutical Society SA 24 June 2018

DIAGNOSIS 2017/2018. Analysing the key trends in the medical schemes industry from 2000 to 2016

Audit of Regional Operations Manitoba Region

Date: 25 th Feb Securities Segment Note on Methodology for Imposition of Volatility Margin

Future Opportunities for Health Insurance in GCC

Risk Management Policy

ASX S APPROACH TO RELEASE MANAGEMENT

Ensure Network Adequacy. May 23, 2017

The Affordable Care Act and the Essential Health Benefits Package

LIMS Reforms and Equitable Subsidies

2018/19 BUDGET AND ANNUAL PERFORMANCE PLAN (APP) ANALYSIS OF THE INDEPENDENT POLICE INVESTIGATIVE DIRECTORATE (IPID): VOTE 20

Therapeutic Goods Amendment (Pharmaceuticals Transparency) Bill Senate Finance and Public Administration Committee

Unit Standard : Apply the principles of budgeting within a municipality. Karel van der Molen

FREQUENTLY ASKED QUESTIONS

Transcription:

PMB Review: What s next? Evelyn Thsehla Clinical Researcher

Contents Background PMB Development Identified Gaps PMB review phases Proposed Intervention Work-plans Conclusion

Background The Medical Schemes Act No. 131 of 1998 introduced prescribed minimum benefits Regulations made in terms of the Act were promulgated on 20 October 1999 and came into force on 1 January 2000 Annexure A to the Regulations defines the Prescribed Minimum Benefits positive list of 270 diagnosis and treatment pairs that must be provided by each scheme, without financial limits in at least one provider setting. 26 Chronic Conditions Emergency Medical Conditions

Background The objective : (i) To avoid incidents where individuals lose their medical scheme cover in the event of serious illness and the consequent risk of unfunded utilisation of public hospitals. (ii) To encourage improved efficiency in the allocation of Private and Public health care resources.

Background: Legislated Mandated NDoH and CMS are required to monitor the impact, effectiveness and appropriateness of the PMB provisions. A review is to be conducted at least every two years by the Department on the basis of: (i) inconsistencies or flaws in the current regulations; (ii) the cost-effectiveness of health technologies or interventions; (iii) consistency with developments in health policy; and (iv) the impact on medical scheme viability and its affordability to members.

Background: Legislated mandate Section 67 The Minister may, after consultation with Council make regulations relating to: The prescribed scope and level of minimum benefits to which members and their registered dependants shall be entitled to under the rules of a medical scheme

PMB Developmental Milestones PMB development began in 1998 Core Package finally adopted in 1999 Regulations linked to core package came into force in January 2000 Costing of the core package was completed in 2002 The algorithms for the 26 CDL were finally published in 2004

Identified Challenges Lack of Diagnosis and Procedure Codes Quality of Coding Splitting Chapters e.g. Obstetrics and neonatal care Public Sector vs. Private Sector Approaches to Treatment

1 st PMB Review: (2008-2015)

Review Objectives Identify gaps or inconsistencies in the current set of prescribed minimum benefits and appropriate measures to address them; Specify of a comprehensive set of essential benefits appropriate for coverage by medical schemes; Identify constraints associated with the implementation of a set of prescribed minimum benefits consistent with the comprehensive set of essential benefits ; Identify measures required to ensure the sustainability of the package of prescribed minimum benefits; Identify specific measures required to ensure the cost efficiency of selected prescribed minimum benefits; and Clarify the relationship that should exist between the prescribed minimum benefits and the public health system.

Principles Legislative and regulatory consistency must be achieved. Risk-pooling must be ensured. It must permit access to essential healthcare for people with and without predictable health needs, with PMBs providing an effective basis for risk equalisation. Essential healthcare, within the context of a contributory third party payer system, must be defined. This includes the removal of inappropriate gaps in the existing DTP and CDL structure. Evidence-based medicine principles must be upheld in the priority setting process. Special care must be taken to ensure that financial resources are allocated to maximise benefits reflecting the priorities of the community being served.

Review Outputs First Review work published Access to comprehensive hospital cover and Access to appropriate out-of-hospital cover In-hospital services: subject to- the Positive list(currently DTPs & CDL) a Negative list Out-of-hospital services: subject to- The Positive list(currently DTPs & CDL) a Negative list; Specified services a basket of defined preventative care a basket of defined primary care a basket of defined basic dentistry a basket of defined basic optometry

Review Outcome Review submitted to NDoH Meeting between CMS and NDoH 2010 PMB review document was not signed by the Minister of Health partly due to the lack of input regarding preventative health care

Key NDOH Concerns Inclusion and exclusion criteria for DTP s and CDL not understood, not robust, not transparent Lack of Primary Health care (disease prevention and health promotion) renders PMB s hospicentric and places them at loggerheads with National Policy Lack of specification of setting and service provider for PMB s not cost effective Exclusion of the Public Health sector as a cost-effective provider of PHC services makes PMB delivery expensive Development and Review of PMB s has to be aligned with key policy initiatives such as the NHI

2 nd PMB Review:(2016-18)

Proposed Intervention and Way Forward Review the whole PMB package Consolidate and update all the work done on PMB s since 2008 Incorporate concerns from NDOH Anchor the review proposal in the NHI context Establish agreement on processes beyond the review outputs

Review Objectives Develop a robust inclusion and exclusion criteria for PMB s based on burden of disease, health needs, Evidence Based Medicine, Affordability and Cost-effectiveness using internationally accepted tools Specify setting and service provider, including the Public Health Sector Ensure a comprehensive primary health care package of services form the core of the PMB s in line with National Policy Ensure that review process is formally closed as per legislation requirement Recommend PMB review frequency

Rationale Current package does not prioritise the needs of the country The current benefit package design does not prioritise primary health care services Current health package covers only emergency medical conditions, CDLs and a limited set of diagnosis and treatment pairs for certain medical conditions. Consistency with developments in health policy Viability and affordability to members

Rationale Pricing and the Cost of the PMB package The cost of PMBs have increased significantly over the years. The cost increased by 13.4% from R556 per beneficiary per month (pbpm) in 2014 to R608 pbpm in 2015 Construct of the PMB package The manner in which PMBs are currently defined makes it difficult for members to prospectively know whether specific benefits are covered or not. Affordability of the PMB package The current PMB package has been shown to be unaffordable to low income earners such as those belonging to the bargaining council schemes. Quality of care The quality of care for the current package has been shown to be poor in a number of conditions classified as PMB

Focus areas Alignment of the PMB package with development in health policy Specification of a comprehensive set of essential healthcare benefits. Identification of actions that should be undertaken to ensure the sustainability of the package. Identification of measures required to ensure affordability of the new package.

Review Goals Reduce burden of disease Improve equity Control moral hazard and cost escalation Improve allocative efficiency Facilitate transparency in accessing healthcare

Proposed methodology Current health situation: burden of diseases Needs of the country: priority areas as stipulated in NDP and NDoH strategic plans NHI Internationally agreed instruments Evidence based medicine Cost effectiveness Affordability

Proposed methodology Specify setting and service provider, including the Public Health Sector Include primary health care package of services Recommend frequency for PMB review

Construct of Package

Proposed work plans Aug - Jan Feb-Mar Apr -Sep Oct-Mar Stakeholder engagements Publication of consultative document Stakeholder engagements Receive submissions on the consultative doc Establishment of advisory committees PMB workshop Clinical advisory committee meetings Cost committee meetings Data collection Stakeholder consultation on proposed package Drafting of regulations

Governance structure Joint Steering Committee (CMS, NDoH, other regulators Project Manager Clinical Advisory Committee on Services Package Costing Committee Legal & Regulatory committee Service Package Sub- Committee e.g. Emergency Services

Conclusion PMB Review process is complex and will require effort and participation from different stakeholders Important that the process is participative, transparent and legally sound Need to create some degree of certainty about PMB s in the transition to the NHI and beyond Need to ensure compliance with PMB review legislation

Thank You!! The End!! e.thsehla@medicalschemes.com